SONIRE Therapeutics Inc.

Healthtech Palo Alto, CA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Healthtech
Headquarters
Palo Alto, CA
Street
214 Homer Ave
Zip
94301

Offering

Total offering
$13.5M
Amount sold
$13.5M
First sale
Mar 31, 2026
Min investment
$0
Securities
Equity, Debt
Federal exemption
Rule 506(b)
Investors so far
1

How this filing compares

Ranked #14 of 63 Healthtech filings in April 2026 by offering amount.

Median Healthtech filing in April 2026: $3.4M. This offering is 4.0× the median.

Other California filings this week: Blue Opportunity Fund, LP, CHECKPOINT CAPITAL (OFFSHORE) FUND LP, CHECKPOINT CAPITAL (ONSHORE) FUND LP, CompleteFarmer Technologies, Inc., ExchangeRight Income Fund Operating Partnership, LP

Leadership

Tohru Satoh — Executive Officer (also: Director, Promoter)

Koji Yasuda — Director

Jun Okamoto — Director

Auriel August — Director

Dennis McWilliams — Director

Filing details

SONIRE Therapeutics Inc. filed a Form D with the SEC on April 15, 2026.

Other newest Healthtech companies

Other newest companies in California